ramelteon has been researched along with Pulmonary Fibrosis in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Aksakalli-Magden, ZB; Alper, F; Aydin, P; Civelek, MS; Halici, Z; Karabulut-Uzuncakmak, S; Mokhtare, B; Ozkaraca, M | 1 |
1 other study(ies) available for ramelteon and Pulmonary Fibrosis
| Article | Year |
|---|---|
The melatonin agonist ramelteon attenuates bleomycin-induced lung fibrosis by suppressing the NLRP3/TGF-Β1/HMGB1 signaling pathway.
Topics: Animals; Bleomycin; HMGB1 Protein; Lung; Melatonin; NLR Family, Pyrin Domain-Containing 3 Protein; Pulmonary Fibrosis; Rats; Signal Transduction; Transforming Growth Factor beta1 | 2023 |